SPATS2 and hepatocellular carcinoma: Moreover, high SPATS2 expression in HCC patients with different TNM stages (TNM I-II or TNM III-IV) also had markedly lower rates of OS and DFS that in patients with low SPATS2 expression (Fig. 2k, l).